- TrialSpark's integrated tech platform and trial model will enable resTORbio to accelerate their clinical trials of RTB-101 for COVID-19 in community/outpatient settings.
PR Newswire
NEW YORK, July 28, 2020
PR Newswire
NEW YORK, July 28, 2020
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey